Latest News about HALO
Recent news which mentions HALO
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
HALO
From Motley Fool
Earnings Scheduled For May 10, 2021
May 10, 2021
From Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
From Benzinga
3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To
April 17, 2021
From Motley Fool
Would Halozyme Make a Good Warren Buffett Stock?
April 04, 2021
From Motley Fool
Are Biotech Stocks a Good Hedge Against Higher Inflation?
March 27, 2021
From Motley Fool
2 Overvalued Biotech Stocks Still Worth Buying
March 04, 2021
From Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
80 Biggest Movers From Yesterday
February 25, 2021
From Benzinga
Why Halozyme Therapeutics Is Trading 14% Higher Today
February 24, 2021
Tickers
HALO
From Motley Fool
61 Stocks Moving In Wednesday's Mid-Day Session
February 24, 2021
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
48 Stocks Moving in Wednesday's Pre-Market Session
February 24, 2021
From Benzinga
Halozyme Therapeutics Inc (HALO) Q4 2020 Earnings Call Transcript
February 23, 2021
Tickers
HALO
From Motley Fool
18 Stocks Moving In Tuesday's After-Hours Session
February 23, 2021
From Benzinga
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
From Benzinga
Earnings Scheduled For February 23, 2021
February 23, 2021
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.